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The title of this symposium implies a simi-
larity which is not obvious between the cell-
ular responses to virus infection and to antigenic 
stimulation. In fact, no analogy between these 
two types of cellular response is apparent either 
from a consideration of the natures of the stimuli, 
a specific nucleotide sequence on the one hand 
and almost any foreign chemical configuration 
on the other, or from an examination of the 
products of the response, identical units in the 
case of the virus and complementary antibody 
units in the case of the antigen. Furthermore, so 
little is known about the mechanisms of the two 
responses at the chemical level that one would 
hesitate to compare them. 
However, viruses, considered both as infective 
agents and as antigens, can induce in cells two 
types of response, the formation of identical 
units, virus particles, and of complementary 
units, antivirus antibodies. What are the prop-
erties of cells which condition their capacity to 
respond in one or the other or both ways? From 
this point of view, attention is focused on the 
1 This symposium was held at the 59th Annual 
Meeting of the Society of American Bacteriologists 
in St. Louis, Missouri, on May 11, 1959, under the 
sponsorship of the Division of Medical Bacteriol-
ogy, Immunology, and Virology, with Dr. R. 
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ability of a cell to perform new syntheses, that 
is, to differentiate under the external stimulus of 
virus or antigen. It is in this way that the rela-
tionship between production of virus and anti-
body, implicit in the title of the symposium, can 
be justified; both phenomena provide a model 
for the study of cellular differentiation. 
When virus and antibody production are con-
sidered as aspects of the same phenomenon, 
i.e., cellular variation, it is not surprising that 
the methodology developed by virologists over 
many years should eventually become useful 
for the study of antibody production. In par-
ticular we are referring to that aspect of the 
methodology which is concerned with analysis 
of the nature and origin of the differences be-
tween single cells. Clearly, it is not necessary to 
justify studies on antibody synthesis in single 
cells to virologists. This would be like breaking 
down an open door. 
Until recently antibody synthesis was studied 
by e:ramining the changes in the serum or in the 
histological characteristics of the lymphatic 
tissue of an animal which had been exposed to a 
given antigen. The study of the serum during 
immunization revealed two extremely significant 
phenomena: the characteristic kinetics of anti-
body formation (reviewed in (1)) and the hetero-
geneity of antibody molecules (reviewed in (2, 
3)). The kinetics of antibody synthesis in the 
animal is of an apparently autocatalytic type, 
subject to a large number of interpretations. 
It is essential to know whether this kinetics is the 
expression of an intrinsic property of the intra-
cellular antibody-forming system, or whether, 
on the contrary, it merely reftects the time at 
which different antibody-forming cells start 
synthesizing and releasing antibody. 
The same alternative between a populational 
and a cellular phenomenon holds for the inter-
pretation of the heterogeneity of antibody mole-
cules. Antibodies directed against a given anti-
genic determinant are markedly heterogeneous, 
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not only with respect to the physicochemical 
properties of the 'Y-globulin with which antibody 
activity is associated, but also with regard to the 
specificity and combining power of the reacting 
sites. Again the problem arises whether the main 
source of variability resides in the properties of 
the antibody-forming system within each cell 
or whether, on the contrary, the heterogeneity 
of antibody has its origin at the level of the anti-
body-producing population, in which different 
cells synthesize slightly different molecules. 
It is pertinent to recall that enzymes, in contrast 
to antibodies, are relatively homogeneous in their 
combining properties (4). If antibody hetero-
geneity were due to differences between antibody-
producing cells, then the situation would be 
analogous to having, for example, a mixed cul-
ture of a yeast and Escherichia coli, in which it 
would be found that a given enzymatic activity 
is associated with a heterogeneous protein frac-
tion. 
There exists today an enormous number of 
observations on the kinetics of antibody syn-
thesis and on the heterogeneity of antibody 
molecules. Since antibody production by an 
animal may involve the activity of a heteroge-
neous population of cells, these findings cannot 
by systematized and interpreted until it is known 
at which level the analysis should be applied. 
Clearly the process must be traced back to its 
cellular origin, and the modifications in the in-
dividual cells following antigenic stimulation 
must be studied. Ideally, we should have a clone 
growing in vitro, induce it de novo to produce a 
given antibody, and then investigate this process 
in individual cells. Unfortunately, such a system 
is not yet available, although we should be op-
timistic and expect that we will not have to 
wait too long for it. Meanwhile, the closest 
alternative is to isolate antibody-producing 
cells from preimmunized animals and study 
antibody production in single surviving cells. 
Any system designed for the study of antibody 
production by a single cell should satisfy the 
following requisites. (a) The assay should be 
sensitive enough not only to detect but also to 
give a quantitative estimate of the antibody 
produced by a single cell; (b) the background 
antibody activity should be low; and (c) the 
assay should be simple enough to allow the 
analysis of a large number of cells, in view of the 
possible heterogeneity of the antibody response 
by the individuals in a population of cells. 
Experiments designed to investigate this 
problem have been reported by· other investi-
gators (5-8). We have developed a method for 
measuring the production of antibody by single 
cells isolated from rabbits hyperimmunized with 
bacteriophage (phage). The assay for antibody 
produced by the cells is based on the measure-
ment of phage inactivation. This system has 
allowed us to obtain a considerable amount of 
information concerning the distribution of anti-
body-producing cells in a lymph node population 
from an immunized rabbit. In particular, our 
study has been directed toward determining 
(a) the proportion of lymph node cells producing 
a given antibody, (b) which morphological 
characteristics of a cell are associated with anti-
body synthesis, and (c) whether the synthetic 
capacity of a single cell is limited to only one 
antibody of a given specificity. The importance 
of the last question may not seem obvious at 
first, but we will have occasion to discUBB it in 
detail later. 
Let us begin by describing a typical experi-
ment and then return later to a discUBBion of the 
controls which the results of this experiment will 
suggest. The rabbit used in this experiment had 
been hyperimmunized by injection, into the 
foot-pads, of the E. coli bacteriophages T2 and 
T5, which are serologically unrelated. A cell 
suspension was prepared from the popliteal 
lymph nodes by a procedure illustrated in figure 
1. The lymph nodes were removed from the 
animal, cut into fairly large fragments, suspended 
in medium, and left under stirring for several 
hours at 0 C. During this time a large number of 
cells were released from the fragments into the 
medium. The cell suspension was filtered through 
a stainless steel wire gauze to separate the large 
fragments of lymph node, and then washed 5 
times to dilute the free antibody present in the 
cell suspension. The cells were then isolated in 
two ways, either in microdrops of the order of 
10-• ml, or in micropipettes in a volume of about 
lO~ml. 
Figure 2 shows the successive steps used to 
dispense the cells in microdrops and to recover 
the drops after incubation. An appropriate 
amount of the phages T2, T5, and Tl was added 
to the cell suspension, which was diluted to 
contain about 108 cells per ml. The phages T2 
and T5, with which the rabbit had been im-
munized, served to test for antibody production 
in the microdrops by the neutralization of their 
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Figure 1. Schematic drawing illustrating the procedure used to prepare the cell suspension from the 
popliteal lymph nodes. 
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Figure I. Schematic drawing representing the successive stepa in an experiment utilizing the micro-
drop technique. 
activity, whereas the phage T1, which does not 
cross react with antibody to T2 or T5, served as a 
microdrop volume indicator. An estimate of the 
volume of the microdrops was necessary for an 
evaluation of the amount of the phages T2 and 
T5 present at the beginning of incubation. 
Twenty-five microdrops were dispensed with a 
micropipette on each large cover slip covered 
with mineral oil. The cells distributed themselves 
in the microdrops so that some drops contained 0 
cells, some 1 cell, and the others 2, 3, or more 
cells. The antibody produced by the cells was 
measured from the inactivation of the phages 
T2 and T5 in the individual drops; the drops 
with no cells were used to estimate the back-
ground inactivation. The number and type of the 
cells in the microdrops were recorded after ex-
amination by phase contrast microscopy. Fol-
lowing 48 hr incubation at 37 C the drops were 
recovered with thin strips of filter paper and 
diluted about 101-fold with nutrient broth. 
The broth was then plated with the indicator 
bacteria for phage assays. Each strain of phage 
was titrated on a different indicator bacterium. 
Figure 3 shows the successive steps in an ex-
periment utilizing micropipettes. Individual 
cells from a dilute suspension containing also 
the phages T2 and T5 were drawn up into care-
fully calibrated micropipettes. The micro-
pipettes were broken at the point indicated in 
figure 3, then sealed with wax. Mter incubation, 
the contents of each micropipette were blown 
out into nutrient broth, which was then assayed 
for phage. 
The microdrop and micropipette techniques 
do not differ in principle. In the former the ad-
vantage of great sensitivity associated with the 
high concentration of antibody attained in the 
small microdrop volume is reduced by the rather 
large background fluctuations due to volumetric 
uncertainties; in the micropipette technique, 
on the other hand, only low antibody concen-
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Figure IJ. Schematic drawing representing the successive steps in an experiment utilizing the micro-
pipette technique. 
trations resulting from dilution in a compara-
tively large volume can be attained but they can 
be measured against very small background 
fluctuations. 
The inactivation of phage by antibody is an 
exponential process described by the equation 
P/Po .. e-ICt/D where Po is the initial phage 
titer, Pis the phage titer after t minutes of con-
tact with antibody, Dis the dilution of the anti-
serum, and K is a colistant that chara.cterizes 
the rate of inactivation of a given phage by a 
given antiserum and gives a measure of the con-
centration of antibody. 
The criterion for scoring a cell as an antibody 
producer in microdrop experiments is illustrated 
by the frequency histograms (figure 4), in which 
only the findings for T2 phage are presented. 
A logarithmic scale for the abscissae has been 
chosen to visualize the exponential relation be-
tween phage inactivation and antibody level. 
In the lower part of figure 4 is shown the fre-
quency distribution of the T2 values, corrected 
for volume, in drops containing 0 cells. Correc-
tion for volume was made by dividing each T2 
count by the corresponding T1 count, and mul-
tiplying the result by 100. This correction is not 
il8 good as we would like it to be, since there is 
still a marked spread of the individual values. 
A broken line has been drawn corresponding to 
-3 u (u - standard deviation) deviation from 
the average, that is, to a 0.001 probability level 
for a normal distribution.T This line has been 
1 The oversimplified criterion of -3 t1 used here 
is somewhat misleading and will be discussed 
subsequently in a detailed paper. Here it suffices 
to say that the data from many of the experiments 
which we have performed do not fit a normal dis-
tribution and other criteria baaed on analysis of 
cumulative frequencies for 0-cell drops have been 
established which for this case give values for 
antibody-producing cella not very different from 
those described here. 
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Figure 4. Frequency histograms of the T2 
values, corrected for volume, of the drops contain-
ing 0 cells (belot.D) and 1 cell (abor~e). A broken line 
baa been drawn corresponding to -3 • deviation 
from the average of the T2 values for the 0 drops. 
Notice that whereas none of the T2 values of the 
0 drops falls beyond this line, many T2 values of 
1 cell drops outrange the -3 • deviation from the 
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Figure 6. Scatter diagram of T2 va. T5 values, 
corrected for volume, for the drops containing 
0 cells. The lines corresponding to -3 • deviation 
from the average for T2 and T5 have been drawn. 
Note that none of the values of the 0 drops falls 
beyond these lines. 
chosen as the cutoff to define inactivation by 
antibody. Drops with values at the left of this 
line will be scored as containing antibody. None 
of the T2 values of the 0 drops falls beyond this 
line. In the upper part of the figure is found the 
frequency distribution of the T2 values, cor-
rected for volume, of the drops containing 1 
cell. In contrast to the 0 drops, many values 
fall beyond the line corresponding to -3 v 
deviation from the control average and, there-
fore, have been interpreted to indicate inactiva-
tion by antibody. The background inactivation 
of phage corresponds to K of the order of lo-'. 
In this experiment the values which fall beyond 
-3 v correspond to inactivation constants 
K > 1o-a, which are at least 10 times greater 
than background. Results similar to those 
shown in this diagram were obtained for the 
phage T5 and identical criteria for defining 
antibody production have been used. 
For the purpose of. correlating the T2 values 
of the individual drops with the corresponding 
T5 values, it has proved convenient to represent 
the results in the form of a scatter diagram in 
which the individual T2 values, corrected for 
volume, are plotted against the corresponding 
T5 values, corrected for volume. Figure 5 shows 
such a type of a scatter diagram for the drops 
containing 0 cells. Here too, a logarithmic plot 
has been used. The lines corresponding to -3 
v deviation from the average for T2 and T5 
are also drawn. One can see that the values of 
these 0 drops do not fall outside the -3 v devia-
tion from the average, either for T2 or for T5. 
This scatter diagram should be compared with 
the one of the drops containing 1 cell (figure 6). 
The values for many 1-cell drops fall beyond the 
line corresponding to -3 v deviation from the 
control average for T2 or T5, or both phages. 
According to the criterion defined above, among 
?31 cells there are 10 anti-T2 cells, 7 anti-T5 
cells, and 3 anti-T2, T5 cells. The points with a 
small arrow adjacent to the abscissae and ordi-
nate axes represent drops in which there was 
complete disappearance of T2 or T5 particles. 
These points have been placed at the measurable 
limit of this experiment. The results we have 
just illustrated, including the data referring to 
the drops containing more than 1 cell, are sum-
marized in table 1. The drops have been classi-
fied according to their cell content, and the num-
ber of anti-T2, anti-T5, and anti-T2,T5 drops, 
considered as three separate classes, have been 
tabulated. We will use these data as an example 
for the subsequent analyses. 
Out of 925 lymph node cells examined, 95 
cells, that is 10.3 per cent, produced detectable 
antibody in the microdrops (table 2). In other 
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Figure 6. Scatter diagram of T2 vs. T5 values, 
corrected for volume, for the drops containing 
1 cell. The lines corresponding to -3 IT deviation 
from the average for T2 and T5 in the 0 drops are 
also drawn. Compare figure 5, and notice that the 
values of many 1 cell drops fall outside the -3 IT 
deviation from the control average for T2 or T5 
or both phages. The points with a small arrow 
adjacent to the abscissae and ordinate axes repre-
sent drops in which there was complete disappear-
ance of T2 or T5 particles. 
experiments the proportion of antibody-produc-
ing cells varied between 10 and 20 per cent. 
If now we consider the difierent claeses of 
antibody-producing cells, we notice that 5.1 
per cent of lymph node cells produced anti-T2 
antibody, and 2.9 per cent anti-T5 antibody. 
The most significant result, however, is that 21 
cells out of 925, that is 2.3 per cent produced 
both anti-T2 and anti-T5 antibody. The value 
of 2.3 per cent for double producers is a mini-
mum one, as is the figure of 10.3 per cent for the 
total proportion of antibody-producing cells. 
In fact, each of the strains of phage contains 
several antigenically difierent proteins and we 
have tested for antibody directed against only 
one of them, namely, the tail protein involved 
in the inactivation reaction. It is entirely con-
ceivable, for example, that many anti-T2 cells 
and anti-T5 cells in this experiment, besides 
making antibody to tail protein, also produced 
antibody against the other phage proteins. 
Now let us turn to another consideration. 
Since the total frequency of anti-T2 cells is 7.4 
per cent and that of anti-T5 cells is 5.2 per cent, 
TABLE 1 
Summarized results of the microdrop experiment 
described in the text 
No. of Cells per Anti-T2 An ti-TS Anti-Drops Drop T2,T5 
220 0 0 0 0 
'01 1 10 7 3 
165 2 19 12 8 
76 3 8 5 10 
35 4 8 2 1 
TABLE 2 
Distribution of antibody-forming cells in the lymph 
node population analyzed in the microdrop 
experiment of table 1 
Total Total Anti-Ex- body Anti- Anti- Anti-am- T2 TS T2,T5 
ined Form-ing 
----- ---- --
No." of cells ..... 925 95 47 27 21 
Per:cent of cells. 100 10.3 5.1 2.9 2.3 
The number of anti-T2, anti-T5, and anti-
T2, T5 cells was calculated from the number of 
inactivating drops and corrected for coincidence. 
the probability of having a cell producing both -
anti-T2 and anti-T5 is 0.38 per cent (table 3), 
assuming that the induced syntheses of antibody 
to T2 and to T5 were two independent events 
liable to occur in any cell of the population (in-
dependence hypothesis). Since the frequency of 
anti-T2, T5 cells in this population is 2.3 per 
cent, much higher than would be expected under 
the independence hypothesis, one might be 
tempted to conclude that production of anti-T2 
and anti-T5 is not independent but is, on the 
contrary, a linked event. However, a value of 
leSB than one for the ratio (F) of the calculated 
frequency of anti-T2,T5 cells to the found fre-
quency, is compatible with several interpreta-
tions, of which only one will be mentioned 
here. 
If it is aBSumed that the lymph node popula-
tion is heterogeneous with respect to the poten-
tial antibody-forming capacity of the individual 
cells, i.e., one fraction of the cells is capable of 
responding to antigen stimulation whereas the 
other is inert, then the independence hypothesis 
could still be valid. F, under this hypothesis, 
is equal to the proportion of the cell population 
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TABLE 3 
ReZationahip between frequencies of anti-TS, 
anti-T6, and anti-TS,T6 cella in the lymph 
node population described in tableS 
P1 "" frequency of anti-T2 cells in total popu-
lation = 0.074 
P 1 • frequency of anti-T5 cells in total popu-
lation - 0.052 
P 1 , 1 a frequency of anti-T2, T5 cells in total 
population (found = 0.023; calculated under 
independence hypothesis = Ps X Pa - 0.074 X 
0.052 = 0.0038). 
Assuming heterogeneity of lymph node population 
(see text): 
Let F ... proportion of potential antibody-formers 
in the population. 
.... a frequency of anti-T2 cells among potential 
antibody formers. 
Ps 
.... = ""i 
... 1 a frequency of anti-T5 cells among potential 
antibody formers. 
P. 
.... """"i 
... 1 , 1 ... probability (or frequency) of anti-T2,T5 
cells among potential antibody formers. !based on observed Ps.a ""' observ;d Ps.l 'll"t.1 expected under independence hypothesis = 
P1 Pa 
11"1 X .... = F X F 
:.P1,1 ... F X P1 X Pa, i.e., 
F = Calculated Ps.a = 0.0038 = 0_17. 
Observed Ps,a 0.023 
potentially able to make antibody as shown in 
table 3. As long as the observed P2,1 is greater 
than the calculated Pz,1 then one can choose a 
value of F < 1 which would reconcile the two 
values. In the present case the data are compat-
ible with the assumption that the population 
consist of 17 per cent potential antibody-pro-
ducing cells and 83 per cent "inert" cells. In-
sufficient data are available to say whether this 
finding is of general significance. 
Another interesting calculation can be made 
from these data. It should be recalled that anti-
body molecules have in general two combining 
sites per molecule (3, 9, 10). Moreover, the 
greatest part, if not all, of the antibody molecules 
in the serum have both sites specific for the same 
antigenic determinant, although the animal has 
been exposed to a large variety of different 
antigens; therefore, a mechanism must exist 
for excluding antibodies with double specificity, 
the so-called heteroligating antibody (11-14). 
The results of our experiments provide an in-
dication as to the level at which this exclusion 
mechanism may operate. In fact (table 2), the 
largest proportion of antibody-producing cells, 
that is, 47 + 27 = 74 out of 95, or 78 per cent, 
produced antibody either against T2 or T5, and 
only 21 out of 95, that is, 22 per cent, produced 
both types of antibody. If in anti-T2,T5 cells, 
the anti-T2 and anti-T5 combining sites were 
formed in the same proportion as they are 
produced by the whole cell population, and if 
they were randomly distributed among the dif-
ferent antibody molecules within each cell, the 
number of single antibody molecules which could 
have different sites, i.e., an anti-T2 and an anti-
T5 site, would be only 10 per cent of the total 
antibody molecules produced by the whole cell 
population. Were this the proportion of hetero-
ligating antibodies present in the sera in previous 
experiments, they would have been difficult to 
detect by the methods applied; in fact it would 
not be necessary to change very much the figures 
obtained in the microdrop experiment analyzed 
above to go below the measurable limit in sero-
logical assays. Therefore, an exclusion mecha-
nism for heteroligating antibodies does operate 
at the cellular level. It remains to be determined 
whether an additional exclusion mechanism also 
operates at the subcellular level. 
An independent analysis was made of the 
distribution of antibody-producing cells in a. 
lymph node population using the micropipette 
technique. The micropipette experiments gave 
results similar to those obtained in the micro-
drop experiments. Table 4 shows the results of 
3 micropipette experiments made with rabbits 
immunized against both T2 a.nd T5. The results 
of the microdrop experiment previously de-
scribed a.re also tabulated. In the micropipette 
experiments, the cells selected under the micro-
scope were mostly of the plasmacytic type. As 
we will discuss later, cells of this type show 
greater frequency of antibody producers than 
cells taken at random. This fact is clearly illus-
trated by the figures presented in tables 4 and 5. 
It should be noticed that a relatively high fre-
quency of double antibody producers, that is 
3 per cent, was found also in the micropipette 
experiments. The fact that comparable results 
were obtained with two independent methods 
gives greater validity to the findings. 
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TABLE 4 
Comparillon of micropipette and microdrop 
ezperiments with cells from rabbits 
immunized with bacteriophagea 
TB and T6 
Micro-
Micropi-d:ctes 
C1au (~ ( ted Cells) 
Cells) (3 Ezpts 
Summi:d) 
% % 
Anti-'1'2 ..................... 5 10 
Anti-T5 ..................... 3 8 
Anti-'1'2, T5 .................. 2 3 
Total antibody-producing .. 10 21 
It is pertinent to an analysis of the distribution 
of antibody-producing cells on a lymph node 
population to ask whether there is any correla~ 
tion between morphological cell types and 
antibody-producing types. Since there might 
be some difference of opinion as to the nomen-
clature, the cell types to which we will refer are 
shown in figure 7, as phase-contrast photographs. 
The name stem, or blast cells, will indicate cells 
like A in figure 7. These are large cells with a 
large nucleus and a rather abundant cytoplasm, 
which is markedly basophilic on staining. We 
will refer to cells, such as B and a, as being of the 
plasmacytic series. Cell B can be considered as an 
immature plasmacyte, whereas cell a is a typical 
mature plasmacyte with the characteristic clear 
area near the eccentric nucleus. Finally, the term 
lymphocyte will refer to cells like D in figure 7. 
The distribution of antibody-producing cells 
among different cell types is shown in table 5. 
In the micropipette experiments, 14 per cent 
of the cells of the lymphocytic series and Zl per 
cent of those of the plasmacytic series showed 
phage-inactivating activity. In one microdrop 
experiment comparable results were obtained. 
It should be noted that stem or blast cells also 
can produce antibody; the reticular cells ex-
amined, on the contrary, are too few to allow 
any conclusion as to their potentialities. These 
:findings are important in that a direct measure-
ment of antibody activity in a single cell has 
been correlated with cell morphological charac-
teristics. Cells of both the plasmacytic and lym-
phocytic series contain and release antibody into 
the medium; this :finding reconciles the divergent 
results obtained by the numerous workers 
(reviewed in (15, 16)) who have investigated 
this problem. 
From the comparison of the proportion of 
antibody-producing cells in the whole cell 
population and in the plasmacytic series, it 
appears that a substantial increase in the pro-
portion of antibody-producing cells can be ob-
tained by selecting for these cells. No correlation 
has been observed between any morphological 
characteristics and amount of antibody de-
tectable in vitro. This point has not been investi-
gated in detail. 
The cells which showed anti-T2, T5 activity 
in the micropipette experiments were all cells 
of the plasmacytic type. It is difficult, however, 
to evaluate at present the significance of this 
result because of the low number of observations. 
Finally, the production of two species of anti-
bodies by a single cell was not found to be asso-
ciated with the presence of two nuclei in the cell. 
The experiments we have just described re-
quire a large number of different controls, 
directed toward answering the following ques-
tions. Is the phage inactivation observed in vitro 
in the presence of cells due to antibody? If 
phage inactivation is due to antibody, is there 
a synthesis of new antibody or a release of pre-
formed antibody? In the case of double inactiva-
tion by a single cell, could this phenomenon be 
accounted for by a passive absorption of anti-
body by nonproducing cells, or by artifacts of 
the techniques? 
Several lines of evidence indicate that the 
phage inactivation observed in vitro in the pres-
ence of cells is due to antibody. In the first place 
this inactivation is cell linked, as shown by three 
facts: (a) there is a linear relationship between 
K and cell concentration in a mass BUBpension; 
(b) the sum of the K's in the individual drops 
accounts roughly for the K of the mass BUBpen-
sion; and (c) the proportion of inactivating 
drops increases with the cell content of the drops 
according to expectations from a Poisson dis-
tribution of the antibody-producing cells. Addi-
tional evidence that antibody is responsible for 
phage inactivation in vitro is brought out by the 
fact that the inactivation is linked to active im-
munization and is not present after passive im-
munization, as we will discUBB later, and by the 
fact that chick anti-rabbit oy-globulin serum 
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Figure 7. Typical lymph node cells photographed in living state in phase contrast. A , stem cell; 
B, immature plasma cell ; C, mature plasma cell; D, small lymphocyte. Magnification, 1680X . 
TABLE 5 
Distribution of antibody-producing cells among different cell types 
Experiments Lymphocytic Plasmacytic Stem Cells (A) Reticular Total Senes (D) Series (B, C) Cells 
Micropipette 
No. cells tested . . . . . . . . . . .. . .. ... . 44 109 16 2 171 
No. Ab producers . .. ..... .... • • • • 0 6 29 2 0 37 
Per cent antibody producers ....... 14 27 13 0 22 
Microdrop 
No. cells tested. . . . . . . . . . . . . . ..... 92 34 2 1 129 
No. Ab producers . . . ....... . 10 11 0 0 21 
Per cent antibody producers ..... 11 32 0 0 16 
The letters in parentheses at the heads of the columns refer to cell types in figure 7. 
protects phage against inactivation by cells as a 
rPsult of neutralization of antiphage antibody. 
As to the problem of whether an actual pro-
duction of new antibody or a release of pre-
formed antibody occurs in vitro, two pieces of 
evidence favor the first alternative. On the one 
hand, the cell suspensions incorporate C14-
labeled amino acids into 'Y-globulin; on the other 
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hand, the antibody which can be extracted from 
the el'lls bl'fore incubation is l<·ss than 10 per 
cent of the amount detectable in the supernatant 
after incubation. 
In order to investigate the possibility of a pas-
sive taking up by some cells of antibody released 
by other cells, several experiments were per-
formed in which cells were isolated from animals 
actively immunized against one strain of phage 
and passively against the other strain. For ex-
ample, in one such experiment the animal was 
actively immunized against T2 and injected 24 
hr prior to sacrifice with -y-globulin isolated from 
800 ml of pooled strong anti-T5 sera. The KT2 
of this animal's serum before this injection was 
2100 and the KT5 was <0.01. At 25 min after 
the injection, the KT5 had increased to 653; 
24 hr later, at the moment of sacrifice, the KT5 
was 200. A total of 298 drops, containing an 
average of 23 cells per drop, were analyzed; 
199 drops, that is 67 per cent, showed anti-T2 
activity. The calculated proportion of anti-T2 
cells was 5 per cent. By way of contrast, no drop 
showed anti-T5 activity and, therefore, the pro-
portion of anti-T5 cells was <0.01 per cent. 
Similar results were obtained with cells taken 
from rabbits immunized actively against T5 
and passively against T2. Within the limits of 
significance of these experiments, such findings 
exclude a passive absorption of antibodies as a 
way of interpreting the presence of bispecific 
antiphage-forming cells. Finally, as a control on 
the technique, a reconstruction experiment was 
made by mixing two cell populations derived 
from two different animals, each one actively 
immunized against only one phage. The failure 
to find any double inactivating single-cell drops 
( <0.4 per cent) with this mixed suspension 
leaves little doubt that double inactivation by a 
single cell could be simulated by errors in the 
scoring of the drops, in their recovery, in plating, 
or by other mistakes. 
SUMMARY 
The evidence presented favors the conclusion 
that one cell can synthesize antibodies to two 
distinct antigens. What are the implications of 
this result? The theories of antibody formation 
can be divided into two classes, depending upon 
the assumption they make regarding the range 
of the antibody-forming capacity of a single 
cell: (a) restrictive theories (17-19), which postu-
!at!• Pitlwr one, or at most, two antibody-forming 
potPntialitiPs in a singll' cPU and (b) unrestrictive 
theories (2Q-23), which do not put a priori any 
restriction to the synthetic capacity of a given 
cell. 
Our results do not support the theories (17, 18) 
which postulate only one antibody-forming 
potentiality per cell. Apart from this, the sig-
nificance which can be attributed to the fact 
that one cell can make antibodies to two dis-
tinct antigens depends on the extrapolation one 
wants to make. If one considers two as the 
maximum numbl'r of antibody-forming poten-
tialities in a given diploid cell, then antibody 
synthesis can be referred in the simplest case to 
some kind of genetic mechanism, with two 
genes per diploid set of chromosomes, each con-
trolling the formation of a specific antibody. 
If one is willing to extrapolate from two to many, 
that is, to consider the antibody-forming capac-
ity of a given cell to be as large as that of the 
animal, then antibody formation may be con-
sidered as a kind of unrestricted inductive proc-
ess. If, finally, one extrapolates from 2 to 3 or 
any low number, then one can think of a genetic 
mechanism with more than two genes involved 
per diploid set of chromosomes, or with a poly-
ploid set of chromosomes, or assume an inductive 
process with some kind of interference or com-
petition between the antigenic stimuli. Further 
speculation along these lines would be unpro-
ductive without additional information. 
The purpose of this paper has not been to spec-
ulate, but rather to illustrate a particular ex-
pl'rimental approach to the problem of antibody 
synthesis. Populational analyses will not eluci-
date the mechanism of antibody synthesis at the 
chemical level, but they will give us the informa-
tion necessary to decide in which direction we 
should go to understand better the nature of the 
antibody response. 
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